Cell Therapy in Heart Failure with Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFpEF) is the most common cause of hospitalisation for heart failure. However, only limited effective treatments are available. Recent evidence suggests that HFpEF may result from a systemic proinflammatory state, microvascular endothelial inflammation...

Descripción completa

Detalles Bibliográficos
Autores principales: Frljak, Sabina, Poglajen, Gregor, Vrtovec, Bojan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2022
Materias:
Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977993/
https://www.ncbi.nlm.nih.gov/pubmed/35399548
http://dx.doi.org/10.15420/cfr.2021.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977993/
https://www.ncbi.nlm.nih.gov/pubmed/35399548
http://dx.doi.org/10.15420/cfr.2021.21

Ejemplares similares